三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图27、奈克替尼与竞品全性对比
图27、奈克替尼与竞品全性对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:195KB
图片尺寸:1028*908
同报告图片
/
4
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
所属报告:
中国生物制药(1177.HK)-港股公司研究报告:加速创新与国际化制药龙头价值重估-250815(56页).pdf
打包全文图表
相关数据
快消品全渠道销售重要性及增速2025年VS.2024年
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
收藏
行业数据
2026-03-31
原图定位
查看详情
图28、奈克替尼与竞品在CD74融合ROS1阳
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
收藏
行业数据
2025-08-19
原图定位
查看详情
无论IGHV突变状态如何,泽布替尼+索托克拉(左图)相比伊布替尼+维奈克
fCDnoJTnqbblkI3np7AgfCBJR0hW56qB5Y+YIHwgSUdIVuacqueqgeWPmCB8IOS4reS9jeaXtumXtO+8iOaciO+8iSB8CnwtLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgQ0VMRVNUSUFMIDEwMSB8IDcuMiAgICAgIHwgNy4xICAgICAgICB8ICAgICAgICAgICAgfAp8IEZMQUlS56CU56m2ICAgfCAxOC4wICAgICB8IDExLjkgICAgICAgfCAgICAgICAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
戈利昔替尼与已获批竞品安全性对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
IBI363vs竞品:治疗末线CRC的疗效与安全性
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
收藏
行业数据
2025-06-03
原图定位
查看详情
TGRX-326片在RP2D时的抗肿瘤活性。(A-C)先前接受克唑替尼治疗的患者、未接受ALKTKI
55Sx5LqO5Zu+54mH5Lit5rKh5pyJ5o+Q5L6b5YW35L2T55qE5pWw5o2u77yM5Zug5q2k5peg5rOV55Sf5oiQ5pWw5o2u6KGo5qC844CC5L2G5piv77yM5oiR5Y+v5Lul5Li65oKo5o+Q5L6b5LiA5Liq56S65L6L6KGo5qC877yM5oKo5Y+v5Lul5qC55o2u5a6e6ZmF5oOF5Ya15aGr5YaZ5pWw5o2u44CCCgp8IOmhueebriB8IOaVsOaNrjEgfCDmlbDmja4yIHwg5pWw5o2uMyB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCDmjIfmoIcxIHwgICB8ICAgfCAgIHwKfCDmjIfmoIcyIHwgICB8ICAgfCAgIHwKfCDmjIfmoIczIHwgICB8ICAgfCAgIHwKCui1hOaWmeadpea6kO+8muWhlOWQieeRnuWFrOS8l+WPt++8jOS4reazsOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-02-25
原图定位
查看详情
安奈克替尼安全性(非头对头)
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
收藏
行业数据
2025-02-10
原图定位
查看详情
截至2024年11月,仅埃克替尼和奥希替尼在我国获批辅助治疗EGFR敏感突变NSCLC
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
收藏
行业数据
2025-01-16
原图定位
查看详情
HMPL-306vs竞品:治疗AML的疗效及安全性比较
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
收藏
行业数据
2024-12-31
原图定位
查看详情
索乐匹尼布vs竞品:安全性
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
收藏
行业数据
2024-12-31
原图定位
查看详情
呋喹替尼vs竞品:治疗3LCRC疗效和安全性
fCDkuLTluornoJTnqbYgfCDlkYvllrnmm7/lsLwgRlJFU0NPLTIgfCDlkYvllrnmm7/lsLwgRlJFU0NPIHwg55Ge5oiI6Z2e5bC8IENPUlJFQ1QgfCDmm7LmsJ/lsL/oi7fmm7/ljLnlmKfllbYgUkVDVVJFIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IOS4tOW6iuWIhuacnyB8IOKFouacnyB8IOKFouacnyB8IOKFouacnyB8IOKFoeacnyB8Cnwg5YiG57uEIHwg6K+V6aqM57uEIHwg5a6J5oWw5YmCIHwg6K+V6aqM57uEIHwg5a6J5oWw5YmCIHwg6K+V6aqM57uEIHwg5a6J5oWw5YmCIHwKfCDmgqPogIXmlbDph4/vvIjkvovvvIkgfCA0NjEgfCAyMzAgfCAyNzggfCAxMzggfCA1MDUgfCAyNTUgfCA1MDIgfCAyNTggfAp8IE9SUiAoJSkgfCAxLjUgfCAwLjAgfCA0LjcgfCAwLjAgfCAxLjAgfCAwLjQgfCAxLjYgfCAwLjQgfAp8IERDUiAoJSkgfCA1NS4wIHwgMTYuMCB8IDYyLjIgfCAxMi4zIHwgNDEuMCB8IDE0LjkgfCA0NC4wIHwgMy4yIHwKfCBQRlMgKOaciCkgfCAzLjcgfCAxLjkgfCAzLjcgfCAxLjggfCAyLjAgfCAxLjcgfCAyLjAgfCAxLjcgfAp8IEhSIHwgMC4zMiB8IE4vQSB8IDAuMjYgfCBOL0EgfCAwLjQ5IHwgTi9BIHwgMC40NyB8IE4vQSB8CnwgT1MgKOaciCkgfCA3LjQgfCA0LjggfCA5LjMgfCA2LjYgfCA2LjQgfCA1LjAgfCA3LjEgfCA1LjMgfAp8IEhSIHwgMC42NiB8IE4vQSB8IDAuNjUgfCBOL0EgfCAwLjc3IHwgTi9BIHwgMC42OCB8IE4vQSB8Cnwg4omlM+e6pyBURUFFICglKSB8IDYyLjcgfCA1MC40IHwgNjEuMiB8IDE5LjcgfCDmnKrmiqvpnLIgfCDmnKrmiqvpnLIgfCA2OS40IHwgNTEuNyB8Cnwg4omlM+e6pyBUUkFFICglKSB8IDM2LjAgfCAxMS4zIHwgNDYuMCB8IDcuMyB8IDU0LjAgfCAxNi4wIHwg5pyq5oqr6ZyyIHwg5pyq5oqr6ZyyIHwKfCBTQUUgKCUpIHwgMzcuNyB8IDM4LjMgfCAxNS41IHwgNS44IHwgNDMuOCB8IDM5LjUgfCAyOS42IHwgMTYuNyB8Cnwg5YGc6I2vIFRFQUUgKCUpIHwgMjAuNCB8IDIxLjMgfCAxNS4xIHwgNS44IHwg5pyq5oqr6ZyyIHwg5pyq5oqr6ZyyIHwgNC4wIHwgMS45IHwKfCDoh7TmrbsgVEVBRSAoJSkgfCAxMC41IHwgMTkuNiB8IDMuMiB8IDEuNSB8IDEuNiB8IDEuMiB8IOacquaKq+mcsiB8IOacquaKq+mcsiB8CgrotYTmlpnmnaXmupDvvJpMYW5jZXQuIDIwMjM7NDAyKDEwMzk1KTo0MS01MywgSkFNQS4gMjAxODszMTkoMjQpOjI0ODYtMjQ5NiwgTGFuY2V0LiAyMDEzOzM4MSg5ODYzKTozMDMtMzEyLCBOIEVuZ2wgSiBNZWQ=
收藏
行业数据
2024-12-31
原图定位
查看详情
赛沃替尼vs竞品:治疗EGFR-TKI耐药NSCLC的疗效及安全性
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
收藏
行业数据
2024-12-31
原图定位
查看详情
赛沃替尼vs竞品:pRCC疗效及安全性
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
收藏
行业数据
2024-12-31
原图定位
查看详情
DZD1516与竞品靶点选择性比较
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
收藏
行业数据
2024-12-17
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
出 ,对脑转移、CD74 融合的 ROS1 突变患者具有差 化势。对比指南内 的 恩曲替尼、克唑替尼两款 品, 奈克替尼在神经毒性与眼部 毒性上显著更低, 全性突出;对 脑转移患者, 奈克替尼相对恩曲替尼展现 非头对头更具 势的 组 mPFS。 奈克替尼成功入选《国 基本医疗保险、工 保险和生育保险药品目 (2024 年)》,该目 2025 年 1 月 1 日起正 执
行业数据
原图定位
当前图表所属:
中国生物制药(1177.HK)-港股公司研究报告:加速创新与国际化制药龙头价值重估-250815(56页).pdf
表9、罗替尼重点1线适症临数据
表4、LM-108临结果
表3、CCR8单抗在研进
表20、可比公司值
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》